Antibody purification is a critical step in the production of therapeutic antibodies, and its importance is reflected in the anticipated value pool of USD 1 billion by the end of 2023 and a projected global demand of USD 3 billion by 2033, marking a CAGR of 11% - a testament to the growing demand for antibody purification services across the biopharmaceutical industry.
| Data Points | Key Statistics |
|---|---|
| Expected Market Value in 2023 | USD 1 billion |
| Projected Market Value in 2033 | USD 3 billion |
| Growth Rate (2022 to 2033) | 11% CAGR |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The demand for high-quality and pure antibodies for research and diagnostic purposes is among eminent drivers of the antibody purification service market. Antibodies are crucial tools in the study of biological systems, and their high specificity and affinity make them valuable reagents for many applications, including research and diagnosis of various diseases.
However, the quality of antibodies can vary significantly, and obtaining pure and highly specific antibodies can be challenging, especially when using traditional methods of antibody production. Antibody purification services offer a solution to this problem, as they enable researchers to obtain highly specific and pure antibodies for their experiments and diagnostic applications.
The increasing use of monoclonal antibodies in the treatment of various diseases is also driving the market. Monoclonal antibodies are highly specific and effective in targeting specific disease markers, and they are becoming an essential tool in the development of novel therapeutics.
However, the production of monoclonal antibodies can be challenging, and the resulting antibodies may require purification to achieve the desired specificity and purity. Antibody purification services can help companies obtain the pure and specific monoclonal antibodies they need for their research and development efforts
The increasing use of antibodies in the field of proteomics is an eminent factor driving the antibody purification service market. Proteomics is the study of the structure and function of proteins, and antibodies are essential tools in this field. They are used to detect and quantify specific proteins in complex mixtures, which is crucial in the study of various biological processes.
However, the purity and specificity of antibodies can significantly impact the accuracy and reliability of proteomic analyses. Antibody purification services can help researchers obtain the specific and pure antibodies they need for their proteomic experiments, thereby driving the growth of the market.
Antibody purification involves isolation of antibody from serum (polyclonal antibody), ascites fluid or culture supernatant of a hybridoma cell line (monoclonal antibody). The global antibody purification services market is expected to grow at a considerable rate during the forecast period. By type the antibody purification services market is divided into 3 categories i.e. physiochemical fractionation, class-specific affinity and antigen-specific affinity.
Based on application, the antibody purification is divided into monoclonal antibodies and polyclonal antibodies and both are expected to generate huge revenues and grow at a rapid rate during the forecast period. With the COVID-19 breakout in December 2019, the disease has affected more than 200 countries. Therefore, it is important to take this into consideration while addressing antibody purification service market.
The disease may have led to temporary lag in the antibody purification service market, but in the long run the antibody purification market is expected to pace up and flourish at a significant rate during the forecast period 2020 to 2030.
Principal Consultant
One of the major factor that drives the growth of antibody purification service market is increasing focus of biopharmaceutical and biotechnology companies towards production of antibody based therapeutics. Increasing rate of infectious diseases is generating a large no. of opportunities for the antibody producing companies to produce more antibodies for the different kind of antigens.
Another factor that is propelling the growth of antibody purification service market is the increasing research activity in life sciences industry along with growing associations between industry and academic centers. However, the high cost of the services may hinder the growth of antibody purification service market in subsequent years.
On the basis of type of application, the monoclonal antibody has been the highest revenue generating segment so far in the antibody purification service market, due to increasing investment in monoclonal antibody research and large no. of antibody-based product launches.
However, the polyclonal antibodies segment is expected to witness significant growth in the forecast period. Easy production process, availability at a low price and diagnosis of the diseases with high proficiency are few of the advantages of polyclonal antibodies. Thus, the increasing popularity of these products is expected to drive the growth of antibody purification service market in future.
On the basis of end user, the pharmaceutical and biotechnology companies are expected to contribute largest revenue share in the antibody purification service market due to large application of these products in the production of antibodies.
Research laboratories is expected to be the second highest revenue generating segment in the antibody purification service market as a result of increasing investment in antibody based research and drug discovery in various countries.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The global antibody purification service market is expected to be dominated by North America due to the presence of many large biotechnology and biopharmaceutical firms in this region.
In addition, rapid growth in healthcare and research infrastructure and the increasing focus on drug discovery in North America is expected to further fuel the antibody purification service market. Europe is considered to have significant growth prospects in the forecasting years due to growing investment in healthcare infrastructure.
However, Asia Pacific is expected experience highest market growth during the forecast periods as a result of untapped opportunities in this region. Another factor that may contribute towards the growth of antibody purification service market in this region is the presence of less stringent regulations for antibody development and production.
Meanwhile, the middle East and Africa are expected to contribute least in the antibody purification service market in the coming years.
Some of the players identified in the warm autoimmune hemolytic anemia market include:
The global antibody purification service market has been segmented on the basis of type, application and end user.
1. Executive Summary 2. Industry Introduction, including Taxonomy and Market Definition 3. Market Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments 4. Global Market Demand Analysis and Forecast, including Historical Analysis and Future Projections 5. Pricing Analysis 6. Global Market Analysis and Forecast 6.1. Type 6.2. Application 6.3. End Use 7. Global Market Analysis and Forecast, By Type 7.1. Physiochemical fractionation 7.2. Class-specific affinity 7.3. Antigen-specific affinity 8. Global Market Analysis and Forecast, By Application 8.1. Monoclonal antibodies 8.2. Polyclonal antibodies 9. Global Market Analysis and Forecast, By End Use 9.1. Pharmaceutical and biotechnology companies 9.2. Research companies 10. Global Market Analysis and Forecast, By Region 10.1. Thermo Fisher 10.2. Detai Bio-tech Co. 10.3. Genscript 10.4. KMD Bioscience 10.5. Southern Biotech 10.6. GE Healthcare 10.7. COVALAB 10.8. Creative Biolab 11. Thermo Fisher Sales Analysis and Forecast, by Key Segments and Countries 12. Detai Bio-tech Co. Sales Analysis and Forecast, by Key Segments and Countries 13. Genscript Sales Analysis and Forecast, by Key Segments and Countries 14. KMD Bioscience Sales Analysis and Forecast, by Key Segments and Countries 15. Southern Biotech Sales Analysis and Forecast, by Key Segments and Countries 16. GE Healthcare Sales Analysis and Forecast, by Key Segments and Countries 17. COVALAB Sales Analysis and Forecast, by Key Segments and Countries 18. Creative Biolab Sales Analysis and Forecast, by Key Segments and Countries 19. Sales Forecast by Type, Application, and End Use for 30 Countries 20. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard 21. Company Profile 21.1. Thermo Fisher 21.2. Detai Bio-tech Co. 21.3. Genscript 21.4. KMD Bioscience 21.5. Southern Biotech 21.6. GE Healthcare 21.7. COVALAB 21.8. Creative Biolab
Explore Healthcare Insights
View Reports
Antibody Purification Service Market
